Browse drugs

…receptor targeted agents (ARTAs) used to treat prostate cancer, enzalutamide1 is a valid option at several stages of the disease. In terms of…

…matinib had 22.86% of the adherence odds compared with those on nilotinib. The findings suggest that maintaining high medication adherenc…

…in/1.73 m 2 or on renal replacement therapy, receiving ≥7500 IU dalteparin daily. Only correctly sampled plasma anti-Xa levels were includ…

…ent-friendly drug regimens. In 2019, a Unitaid-led deal reduced rifapentine costs by over 70%, facilitating Brazil’s implementation of 3 mo…

…Aims and Objectives Paracetamol overdose is a common presentation among paediatric patients in …

…Aims and Objectives Paracetamol overdose accounts for over 100,000 UK Emergency Department (ED)…

…e duration, higher cumulative dose of prednisone and the use of cyclophosphamide.Trial registration number NCT04534647.…

… enhancement of pyroptosis and ferroptosis. In the in vivo mice pristane model, the isolated renal epithelial cells and macrophages from…

…The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual gut hormone therapies has revolutionised obesity trea…

…isease. Patients receive six 3-week cycles of systemic therapy: pucotenlimab 200 mg IV on day 1; TMZ 200 mg/m² orally on days 1–5 and DDP 25…

…all three culture-positive gonococcal isolates were tolerant to ceftriaxone.Results Over a period of 6 months, a transgender man with gonoc…

…le patients will be randomised in a 1:1 ratio to receive either dapagliflozin (10 mg once daily) or a matching placebo for a duration of 1 ye…